EPS Bio Technology Corp. (TPEX:4183)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostic Kits / Equipment	499.70M	451.08M	470.17M	463.45M	480.28M
Total	499.70M	451.08M	470.17M	463.45M	480.28M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Germany	206.87M	188.18M	229.76M	273.85M	336.08M
Iran	114.47M	79.09M	80.51M	43.65M	3.45M
Saudi Arabia	51.67M	63.27M	37.19M	52.73M	32.82M
United States	26.43M	22.27M	23.69M	22.32M	-
Switzerland	24.60M	28.78M	37.10M	31.50M	42.48M
Others	75.68M	69.50M	61.92M	39.41M	65.46M
Total	499.70M	451.08M	470.17M	463.45M	480.28M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error